Scarica l'app Stockscreener
6.45
4.59%
-0.31
Dopo l'orario di chiusura:
6.36
-0.09
-1.40%
Day One Biopharmaceuticals Inc Borsa (DAWN) Ultime notizie
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Shares Purchased by Dimensional Fund Advisors LP - Defense World
Research Analysts Issue Forecasts for DAWN Q2 Earnings - Defense World
Needham & Company LLC Cuts Day One Biopharmaceuticals (NASDAQ:DAWN) Price Target to $27.00 - Defense World
Research Analysts Set Expectations for DAWN Q2 Earnings - Defense World
Is Day One Biopharmaceuticals, Inc. (DAWN) the Low Risk High Reward Stock Set to Triple by 2030? - Insider Monkey
Analysts Issue Forecasts for DAWN Q1 Earnings - Defense World
10 Low Risk High Reward Stocks Set to Triple by 2030 - Insider Monkey
Day One Biopharmaceuticals (NASDAQ:DAWN) Shares Gap Up After Earnings Beat - Defense World
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Shares Sold by Mariner LLC - Defense World
Day one biopharmaceuticals highlights OJEMDA revenue growth and pipeline progress in Q1 2025 - MSN
Day One Biopharmaceuticals (NASDAQ:DAWN) Reaches New 12-Month Low Following Analyst Downgrade - Defense World
Day One Biopharma’s Earnings Call Highlights Growth - TipRanks
Day One Biopharmaceuticals (DAWN) Target Price Adjusted to $26 | DAWN Stock News - GuruFocus
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Q1 2025 Earnings Call Transcript - Insider Monkey
MetLife Investment Management LLC Raises Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World
Day One Biopharmaceuticals earnings beat by $0.07, revenue fell short of estimates - Investing.com Canada
Day One Biopharmaceuticals Reports Strong Q1 2025 Results - TipRanks
Day One Biopharmaceuticals Inc (DAWN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth ... By GuruFocus - Investing.com Canada
Day One Reports First Quarter 2025 Financial Results and Corporate Progress - GlobeNewswire
Earnings call transcript: Day One Biopharmaceuticals beats Q1 2025 EPS forecast - Investing.com
Day One Biopharmaceuticals Q1 2025 slides: OJEMDA revenue grows 11% amid market challenges - Investing.com Canada
Day One Biopharmaceuticals, Inc. (DAWN) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Day One Biopharmaceuticals, Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:DAWN) - Seeking Alpha
Day One Biopharmaceuticals Inc (DAWN) Q1 2025 Earnings Report Pr - GuruFocus
Day One Biopharmaceuticals Inc (DAWN) Q1 2025 Earnings Report Preview: What to Expect - GuruFocus
Day One Biopharmaceuticals (DAWN) Projected to Post Quarterly Earnings on Tuesday - Defense World
Holdings of Day One Biopharmaceuticals Inc (DAWN) are aligned with the stars - Sete News
Wells Fargo & Company MN Sells 4,744 Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World
Is Day One Biopharmaceuticals Inc (DAWN) worth investing in despite its overvalued state? - uspostnews.com
Examining the Potential Price Growth of Day One Biopharmaceuticals Inc (DAWN) - knoxdaily.com
Market Momentum Report: Xeris Biopharma Holdings Inc (XERS)’s Positive Close at 4.41 - DWinneX
Azitra Inc (AZTR)’s Day in Review: Closing at 0.30, Down by -6.51 - DWinneX
SuperCom Ltd (SPCB)’s Day in Review: Closing at 6.19, Down by -22.04 - DWinneX
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Stock Holdings Decreased by Legal & General Group Plc - Defense World
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Given Average Rating of “Buy” by Analysts - Defense World
DAWN Stock Sees Surge of Approximately 16.86% in Last Five Days - knoxdaily.com
Wedbush Brokers Decrease Earnings Estimates for DAWN - Defense World
How did Metsera Inc (MTSR) fare last session? - uspostnews.com
Market Highlights: Day One Biopharmaceuticals Inc (DAWN) Ends on a High Note at 7.14 - DWinneX
Day One to Report First Quarter 2025 Financial Results Tuesday, May 6, 2025 - GlobeNewswire
Day One Q1 2025 Earnings: Live Webcast Details and Key Updates Coming May 6 - Stock Titan
What is Day One Biopharmaceuticals Inc (DAWN) Stock Return on Shareholders’ Capital? - Sete News
Finance Watch: No Big Post-ASCO Follow-On Frenzy, But Biotech Had A Good Week - insights.citeline.com
Geode Capital Management LLC Has $18.54 Million Holdings in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World
BofA Adjusts Price Target on Day One Biopharmaceuticals to $21 From $24, Keeps Buy Rating - marketscreener.com
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Shares Sold by Corebridge Financial Inc. - Defense World
Vanguard Group Inc. Lowers Stock Holdings in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World
Day One Biopharmaceuticals Pullback Is A Potential Buying Opportunity - Seeking Alpha
Day One Biopharmaceuticals, Inc. (DAWN): Among Stocks Under $10 that Will Triple - MSN
KLP Kapitalforvaltning AS Invests $150,000 in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World
10 Stocks Under $10 that Will Triple - Insider Monkey
HC Wainwright Analysts Decrease Earnings Estimates for DAWN - Defense World
HC Wainwright Reaffirms Buy Rating for Day One Biopharmaceuticals (NASDAQ:DAWN) - Defense World
H.C. Wainwright maintains Buy on Day One Biopharmaceuticals By Investing.com - Investing.com Canada
Have you been able to find a good deal on Day One Biopharmaceuticals Inc’s shares? - uspostnews.com
Teacher Retirement System of Texas Buys 3,086 Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
0.84%
0.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):